GENE WRITING Trademark

Trademark Overview

On Friday, July 24, 2020, a trademark application was filed for GENE WRITING with the United States Patent and Trademark Office. The USPTO has given the GENE WRITING trademark a serial number of 90071417. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 27, 2023. This trademark is owned by Tessera Therapeutics, Inc.. The GENE WRITING trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of technology and engineering for the modification of DNA; development of new technology for others for enabling the engineering and modification of DNA, namely, developing molecular and cellular biology reagents, techniques, and assays for the modification of cells and DNA
gene writing

General Information

Serial Number90071417
Word MarkGENE WRITING
Filing DateFriday, July 24, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesResearch and development in the field of technology and engineering for the modification of DNA; development of new technology for others for enabling the engineering and modification of DNA, namely, developing molecular and cellular biology reagents, techniques, and assays for the modification of cells and DNA

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code042
First Use Anywhere DateFriday, December 3, 2021
First Use In Commerce DateFriday, December 3, 2021

Trademark Owner History

Party NameTessera Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, March 28, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, March 27, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, March 27, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, December 2, 2022ASSIGNED TO EXAMINER
Monday, September 12, 2022NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, September 12, 2022SUBSEQUENT FINAL EMAILED
Monday, September 12, 2022SUBSEQUENT FINAL REFUSAL WRITTEN
Friday, August 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 11, 2022NON-FINAL ACTION E-MAILED
Friday, February 11, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 7, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, December 6, 2021USE AMENDMENT ACCEPTED
Saturday, December 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 3, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, December 4, 2021AMENDMENT TO USE PROCESSING COMPLETE
Saturday, December 4, 2021USE AMENDMENT FILED
Friday, December 3, 2021TEAS AMENDMENT OF USE RECEIVED
Thursday, June 3, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, June 3, 2021FINAL REFUSAL E-MAILED
Thursday, June 3, 2021FINAL REFUSAL WRITTEN
Wednesday, May 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 12, 2020NON-FINAL ACTION E-MAILED
Thursday, November 12, 2020NON-FINAL ACTION WRITTEN
Tuesday, November 10, 2020ASSIGNED TO EXAMINER
Friday, August 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

writing gene modification technology engineering development reagents biology techniques assays cellular cells